Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Michael Millenson"'
Autor:
John L. Wagner, Lindsay Wilde, Neil Palmisiano, Ubaldo E. Martinez-Outschoorn, Pierluigi Porcu, Gina Keiffer, Joanne Filicko-O'Hara, Dolores Grosso, Allison Zibelli, Matthew Carabasi, Neal Flomenberg, Michael Millenson, Onder Alpdogan, Thomas R. Klumpp, Usama Gergis, Amy R. MacKenzie, Adam Binder, Margaret Kasner
Publikováno v:
Blood
Introduction :The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent coronavirus-19 (COVID-19) pandemic has impacted hematologic malignancies (HM) care worldwide. Reported risk factors for severe COVID-19 pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e29f8e31df903ffeea6ec32d945e61
http://europepmc.org/articles/PMC8330274
http://europepmc.org/articles/PMC8330274
Autor:
Julia Judd, Hossein Borghaei, Tianyu Li, Mitchell R. Smith, Tahseen Al-Saleem, Essel Dulaimi, Michael Millenson
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:83-88
Background Tumor-infiltrating immune cells influence diffuse large B-cell lymphoma (DLBCL) outcomes. Relatively little, however, is known about the significance of peripheral blood immune cell numbers on DLBCL behavior. Patients and Methods In the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f7696424bbaadefcf430ebeeaa39569
https://doi.org/10.1016/j.clml.2016.11.005
https://doi.org/10.1016/j.clml.2016.11.005
Autor:
Madhav V. Dhodapkar, Philippe Armand, Alexander M. Lesokhin, Stephen M. Ansell, Martin Gutierrez, Emma C. Scott, Stephen J. Schuster, Adam D. Cohen, Scott J. Rodig, Margaret A. Shipp, Joseph F. Grosso, David Avigan, Michael Millenson, John M. Timmerman, Daniel Lebovic, Lili Zhu, Azra H. Ligon, Bjoern Chapuy, Ivan Borrello, Deepika Cattry, Ahmad Halwani, Gordon J. Freeman, M. Brigid Bradley Garelik
Publikováno v:
Journal of Clinical Oncology. 34:2698-2704
Purpose Cancer cells can exploit the programmed death-1 (PD-1) immune checkpoint pathway to avoid immune surveillance by modulating T-lymphocyte activity. In part, this may occur through overexpression of PD-1 and PD-1 pathway ligands (PD-L1 and PD-L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c950f7acc87b04e7f901fd517cefe60
https://doi.org/10.1200/jco.2015.65.9789
https://doi.org/10.1200/jco.2015.65.9789
Autor:
Alfred Lee, Paul C. Hendrie, Paula L. Bockenstedt, Colleen Morton, Randolph B. Fenninger, Shuwei Gao, Annemarie E. Fogerty, Jason T. Lee, Bjorn Holmstrom, Samuel Z. Goldhaber, Dana Angelini, Anaadriana Zakarija, Michael B. Streiff, Anita M. Engh, Kristi J. Smock, Thomas L. Ortel, Krishna Gundabolu, Sadat Ozair, Janelle Mann, Gerald A. Soff, Michael Millenson, Tanya Siddiqi, Brandon McMahon, Lydia J. Hammond, Mary A. Dwyer, Carolyn M. Chesney, Tzu-Fei Wang, Rita Paschal, Aneel A. Ashrani, John Fanikos, Sanford J. Shattil, Eliot C. Williams
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 16(11)
Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3fa54d60eac011d3dabc9aa8d78d6c0
https://pubmed.ncbi.nlm.nih.gov/30442731
https://pubmed.ncbi.nlm.nih.gov/30442731
Autor:
Ivan Borrello, Scott J. Rodig, Gordon J. Freeman, John M. Timmerman, Deepika Cattry, Michael Millenson, Bjoern Chapuy, Ahmad Halwani, Su Y oung Kim, Philippe Armand, Azra H. Ligon, Lili Zhu, Stephen M. Ansell, Stephen J. Schuster, Joseph F. Grosso, Alexander M. Lesokhin, Martin Gutierrez, Emma C. Scott, Margaret A. Shipp
Publikováno v:
New England Journal of Medicine. 372:311-319
BACKGROUND Preclinical studies suggest that Reed–Sternberg cells exploit the programmed death 1 (PD-1) pathway to evade immune detection. In classic Hodgkin’s lymphoma, alterations in chromosome 9p24.1 increase the abundance of the PD-1 ligands,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d596be0099fe8102037a58d116af26
https://doi.org/10.1056/nejmoa1411087
https://doi.org/10.1056/nejmoa1411087
Autor:
Ann S. LaCasce, Leo I. Gordon, Michael Millenson, Ann Vanderplas, Bouthaina S. Dabaja, Joyce C. Niland, Mark S. Kaminski, Auayporn Nademanee, Allison Crosby-Thompson, Maria Alma Rodriguez, Jonathan W. Friedberg, Myron S. Czuczman, Gregory A. Abel, Andrew D. Zelenetz
Publikováno v:
Cancer. 121:1032-1039
BACKGROUND The role of consolidation radiotherapy was examined for patients with diffuse large B-cell lymphoma who were treated at institutions of the National Comprehensive Cancer Network during the rituximab era. METHODS Failure-free survival (FFS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::598076dbfcd5abb866a63a6d5979c740
https://doi.org/10.1002/cncr.29113
https://doi.org/10.1002/cncr.29113
Autor:
Nashat Y. Gabrail, Bin Wu, Hervé Tilly, John Hayslip, Ann Janssens, Oliver G. Ottmann, Lei Gao, Michael Millenson, Fritz Offner, Jeanette K. Doorduijn, Coumaran Egile, Mehdi Hamadani, Jennifer R. Brown, Marie José Kersten, Nina D. Wagner-Johnston, Jon E. Arnason, Siddha Kasar, Arnon P. Kater, Sikander Ailawadh, Joanne Lager, Siddhartha Ganguly
Publikováno v:
Lancet. Haematology, 5(4), e170-e180. Lancet Publishing Group
Lancet Haematology, 5(4), E170-E180. Lancet Publishing Group
Lancet Haematology, 5(4), E170-E180. Lancet Publishing Group
Background\ud \ud Patients with relapsed or refractory lymphoma or chronic lymphocytic leukaemia have a poor prognosis. Therapies targeting more than one isoform of PI3K, as well as mTOR, might increase antitumour activity. We aimed to investigate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd8e3e355700dce3555f9c690f5ec710
https://pubmed.ncbi.nlm.nih.gov/29859612
https://pubmed.ncbi.nlm.nih.gov/29859612
Autor:
Andrew M. Evens, Leo I. Gordon, Jane N. Winter, Steve Rosen, Michael Millenson, Mitchell R. Smith, Izidore S. Lossos, Irene Helenowski
Publikováno v:
British Journal of Haematology. 166:514-520
Summary There is a lack of published data examining non-cytotoxic options for the frontline treatment of patients with high-tumour burden (HTB) indolent non-Hodgkin lymphoma (iNHL). We completed a multicentre phase II study for patients with untreate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c57cb333929d5b948932c2ff000786e
https://doi.org/10.1111/bjh.12915
https://doi.org/10.1111/bjh.12915
Autor:
Leo I. Gordon, Auayporn Nademanee, Alex F. Herrera, Allison Crosby-Thompson, Michael Millenson, Gregory A. Abel, Mark S. Kaminski, Joyce C. Niland, Maria Alma Rodriguez, Myron S. Czuczman, Andrew D. Zelenetz, Jonathan W. Friedberg, Ann S. LaCasce, Scott J. Rodig
Publikováno v:
Cancer. 120:1993-1999
BACKGROUND T-cell lymphomas (TCLs) are uncommon in the United States. The accurate diagnosis of TCL is challenging and requires morphologic interpretation, immunophenotyping, and molecular techniques. The authors compared pathologic diagnoses at refe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdf32636ed1508f6af3d6cb2f75b5286
https://doi.org/10.1002/cncr.28676
https://doi.org/10.1002/cncr.28676
Autor:
Madelyn Feder, Jianming Pei, Erin Neumann-Domer, Jacqueline Talarchek, Essel Dulaimi, Joseph R. Testa, Michael Millenson, Mitchell Cheung, Valentin G. Robu
Publikováno v:
Cancer Genetics. 207:98-102
Single nucleotide polymorphism (SNP)-based chromosome microarray analysis was used to uncover copy neutral loss of heterozygosity (LOH) in the long arm of chromosome 20 in blood or bone marrow specimens from three patients with chronic lymphocytic le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2422a4f651e039d72ca4f2d2503969c
https://doi.org/10.1016/j.cancergen.2014.02.005
https://doi.org/10.1016/j.cancergen.2014.02.005